90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the ... commercial launch in 2027.” Poster Presentation Details Title: OPERA-01: A ...

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation ... presented in a poster entitled ...

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation ... presented in a poster entitled: ...

"We are honored that our Trial in Progress poster has been accepted for presentation at ASCO 2025," said Anastasios Maniakas, MD, PhD, Assistant Professor in the Department of Head and Neck ...

"We are honored that our Trial in Progress poster has been accepted for presentation at ASCO 2025," said Anastasios Maniakas, MD, PhD, Assistant Professor in the Department of Head and Neck Surgery ...

NEW YORK -- The second week of testimony in the sex trafficking trial of Sean "Diddy" Combs began on Monday. Combs has been accused of sex trafficking by force, transportation to engage in ...

today announced that a Trial in Progress poster for its first-in-human, Phase 1/2 study of its first-in-class oral DHX9 inhibitor, ATX-559, will be presented at the 2025 American Society of ...

TBILISI, May 22 (Reuters) - A Georgian court on Thursday placed Zurab Japaridze, one of the leaders of the country's largest opposition party, in pre-trial detention, as the government clamps down ...